The enzyme IPMK physically attaches to HDAC3 to enable the production of InsP6, and this interaction is required for HDAC3 to become active.

We’ve reviewed the available evidence on whether IPMK binds to HDAC3 to activate it through InsP6 synthesis, and what we’ve found so far points to a proposed mechanism where IPMK physically attaches to HDAC3 to support the production of InsP6, and this interaction appears necessary for HDAC3 to become active [1]. All eight studies or assertions we examined support this idea, with none contradicting it. IPMK is an enzyme involved in making inositol hexakisphosphate, or InsP6 — a molecule that plays roles in cellular signaling. HDAC3 is another enzyme that helps regulate gene activity by removing chemical tags from DNA-associated proteins. The evidence suggests that when IPMK connects directly to HDAC3, it may help generate InsP6 right at the site, and this local production could be needed for HDAC3 to function properly. While no studies in our review challenge this link, the number of assertions remains small — only one detailed claim was analyzed, supported by eight reports that all align with it. We don’t yet know how strong or consistent this interaction is across different cell types or conditions. The mechanism is described as required for activation, but the depth of experimental validation isn’t clear from what we’ve seen. What this means for now is that there’s a consistent, unchallenged suggestion that IPMK and HDAC3 work together in this specific way, but more research would be needed to understand how broadly this applies or how it might vary in different parts of the body. If you’re exploring how cellular signaling affects health, this interaction could be one piece of a larger puzzle — but it’s still early to say how much it matters in real-world outcomes.